IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Saltigo Opens cGMP Plant; Eyes Accelerated Growth

9:38 AM MST | February 25, 2008 | Natasha Alperowicz

Saltigo (Langenfeld, Germany), the wholly owned fine chemical subsidiary of Lanxess, has officially inaugurated a €10-million ($14.5 million), state-of-the-art cGMP custom manufacturing facility at Leverkusen and pledged to invest €50 million through 2009 to position the business for further growth. The four-module, multipurpose cGMP unit, dubbed O10, can produce more than 200 m.t./year of advanced pharmaceutical intermediates (API), registered intermediates, and starting compounds for the pharmaceutical industry. It adds about 25% to Saltigo’s...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa